Pharmakonsulenterne IVS
Credit rating
Company information
About Pharmakonsulenterne IVS
Pharmakonsulenterne IVS (CVR number: 40270442) is a company from ODSHERRED. The company recorded a gross profit of -1.5 kDKK in 2020. The operating profit was -1.5 kDKK, while net earnings were -1.5 kDKK. The profitability of the company measured by Return on Assets (ROA) was -16.2 %, which can be considered poor and Return on Equity (ROE) was -31.9 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 46.6 %, a level that can be considered to be modest. This means a balanced mix of debt and equity financing its assets—a typical operational level for many companies. Pharmakonsulenterne IVS's liquidity measured by quick ratio was 1.9 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsGross profit (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2019 | 2020 | |
---|---|---|
Volume | ||
Net sales | ||
Gross profit | -4.54 | -1.50 |
EBIT | -4.54 | -1.50 |
Net earnings | -4.54 | -1.50 |
Shareholders equity total | 5.46 | 3.96 |
Balance sheet total (assets) | 10.00 | 8.50 |
Net debt | -10.00 | -8.50 |
Profitability | ||
EBIT-% | ||
ROA | -45.4 % | -16.2 % |
ROE | -83.2 % | -31.9 % |
ROI | -83.2 % | -31.9 % |
Economic value added (EVA) | -4.54 | -1.27 |
Solvency | ||
Equity ratio | 54.6 % | 46.6 % |
Gearing | ||
Relative net indebtedness % | ||
Liquidity | ||
Quick ratio | 2.2 | 1.9 |
Current ratio | 2.2 | 1.9 |
Cash and cash equivalents | 10.00 | 8.50 |
Capital use efficiency | ||
Trade debtors turnover (days) | ||
Net working capital % | ||
Credit risk | ||
Credit rating | B | B |
Variable visualization
Companies in the same industry
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.